Novozymes A/S (OTCMKTS:NVZMY) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $61.62 and traded as low as $59.43. Novozymes A/S shares last traded at $60.27, with a volume of 13,732 shares traded.

Analyst Ratings Changes

Separately, Barclays upgraded Novozymes A/S to a “strong-buy” rating in a research note on Monday, November 18th.

Novozymes A/S Stock Up 1.8 %

The stock has a market cap of $28.22 billion, a PE ratio of 38.15, a price-to-earnings-growth ratio of 3.87 and a beta of 0.88. The firm has a fifty day moving average of $56.75 and a 200 day moving average of $61.60.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.